Table of Content

Table of Contents

Global Poxviridae Infections Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 CJ-40011 -Product Introduction and Major Manufacturers
1.1.2 24a -Product Introduction and Major Manufacturers
1.1.3 BA-368 -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Poxviridae Infections Drug Status and Prospect (2015-2026)
2.1.1 China Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Poxviridae Infections Drug Status and Prospect (2015-2026)
2.2.1 EU Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Poxviridae Infections Drug Status and Prospect (2015-2026)
2.3.1 USA Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Poxviridae Infections Drug Status and Prospect (2015-2026)
2.4.1 Japan Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Poxviridae Infections Drug Status and Prospect (2015-2026)
2.5.1 India Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Poxviridae Infections Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Poxviridae Infections Drug Status and Prospect (2015-2026)
2.7.1 South America Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Poxviridae Infections Drug Status and Prospect (2015-2026)
2.8.1 Poxviridae Infections Drug Market Size and Growth Rate (2015-2026)
2.8.2 Poxviridae Infections Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Poxviridae Infections Drug Market Assessment by Segment
3.1 Global Poxviridae Infections Drug Capacity and Growth Rate
3.2 Global Poxviridae Infections Drug Sales by Type
3.3 Global Poxviridae Infections Drug Sales Revenue by Type
3.4 Global Poxviridae Infections Drug Consumption by Application
4 Global Poxviridae Infections Drug Market Assessment by Regions
4.1 Global Poxviridae Infections Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Poxviridae Infections Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Poxviridae Infections Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Poxviridae Infections Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Poxviridae Infections Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Poxviridae Infections Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Poxviridae Infections Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Poxviridae Infections Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Poxviridae Infections Drug Competitive Analysis
7.1 Bavarian Nordic A/S
7.1.1 Bavarian Nordic A/S Company Profiles
7.1.2 Bavarian Nordic A/S Product Introduction
7.1.3 Bavarian Nordic A/S Poxviridae Infections Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 BioFactura, Inc.
7.2.1 BioFactura, Inc. Company Profiles
7.2.2 BioFactura, Inc. Product Introduction
7.2.3 BioFactura, Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 CEL-SCI Corporation
7.3.1 CEL-SCI Corporation Company Profiles
7.3.2 CEL-SCI Corporation Product Introduction
7.3.3 CEL-SCI Corporation Poxviridae Infections Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Chimerix, Inc.
7.4.1 Chimerix, Inc. Company Profiles
7.4.2 Chimerix, Inc. Product Introduction
7.4.3 Chimerix, Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 China Biologic Products, Inc.
7.5.1 China Biologic Products, Inc. Company Profiles
7.5.2 China Biologic Products, Inc. Product Introduction
7.5.3 China Biologic Products, Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 CJ HealthCare Corp.
7.6.1 CJ HealthCare Corp. Company Profiles
7.6.2 CJ HealthCare Corp. Product Introduction
7.6.3 CJ HealthCare Corp. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 EpiVax, Inc.
7.7.1 EpiVax, Inc. Company Profiles
7.7.2 EpiVax, Inc. Product Introduction
7.7.3 EpiVax, Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 N & N Pharmaceuticals Inc.
7.8.1 N & N Pharmaceuticals Inc. Company Profiles
7.8.2 N & N Pharmaceuticals Inc. Product Introduction
7.8.3 N & N Pharmaceuticals Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 SIGA Technologies, Inc.
7.9.1 SIGA Technologies, Inc. Company Profiles
7.9.2 SIGA Technologies, Inc. Product Introduction
7.9.3 SIGA Technologies, Inc. Poxviridae Infections Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Company Profiles
7.10.2 Takeda Pharmaceutical Company Limited Product Introduction
7.10.3 Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Tonix Pharmaceuticals Holding Corp.
7.12 Verrica Pharmaceuticals Inc.
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Poxviridae Infections Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Poxviridae Infections Drug Sales (K Unit) by Type (2015-2026)
Figure Global Poxviridae Infections Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Poxviridae Infections Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Poxviridae Infections Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Poxviridae Infections Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Poxviridae Infections Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Poxviridae Infections Drug Sales (K Unit) by Application (2015-2026)
Figure China Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Poxviridae Infections Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Poxviridae Infections Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Poxviridae Infections Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Poxviridae Infections Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Poxviridae Infections Drug Sales (Unit) by Type (2015-2026)
Figure Global Poxviridae Infections Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Poxviridae Infections Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Poxviridae Infections Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Poxviridae Infections Drug Consumption (Unit) by Application (2015-2026)
Figure Global Poxviridae Infections Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Poxviridae Infections Drug Production (K Unite) by Regions (2015-2020)
Table Global Poxviridae Infections Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Poxviridae Infections Drug Production Share by Regions (2019-2020)
Table Global Poxviridae Infections Drug Sales (K Unite) by Regions (2015-2020)
Table Global Poxviridae Infections Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Poxviridae Infections Drug Sales Share by Regions (2019-2020)
Table Global Poxviridae Infections Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Poxviridae Infections Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Poxviridae Infections Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Poxviridae Infections Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Poxviridae Infections Drug
Figure Cost Structure of Poxviridae Infections Drug in 2020
Table Global Poxviridae Infections Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Poxviridae Infections Drug Capacity Share of Manufacturers (2019-2020)
Table Global Poxviridae Infections Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Poxviridae Infections Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Poxviridae Infections Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Poxviridae Infections Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Poxviridae Infections Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ??Bavarian Nordic A/S Profiles
Table ??Bavarian Nordic A/S Poxviridae Infections Drug Product Introduction
Table ??Bavarian Nordic A/S Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ??Bavarian Nordic A/S SWOT Analysis
Table ????BioFactura, Inc. Profiles
Table ????BioFactura, Inc. Poxviridae Infections Drug Product Introduction
Table ????BioFactura, Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????BioFactura, Inc. SWOT Analysis
Table ????CEL-SCI Corporation Profiles
Table ????CEL-SCI Corporation Poxviridae Infections Drug Product Introduction
Table ????CEL-SCI Corporation Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????CEL-SCI Corporation SWOT Analysis
Table ????Chimerix, Inc. Profiles
Table ????Chimerix, Inc. Poxviridae Infections Drug Product Introduction
Table ????Chimerix, Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Chimerix, Inc. SWOT Analysis
Table ????China Biologic Products, Inc. Profiles
Table ????China Biologic Products, Inc. Poxviridae Infections Drug Product Introduction
Table ????China Biologic Products, Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????China Biologic Products, Inc. SWOT Analysis
Table ????CJ HealthCare Corp. Profiles
Table ????CJ HealthCare Corp. Poxviridae Infections Drug Product Introduction
Table ????CJ HealthCare Corp. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????CJ HealthCare Corp. SWOT Analysis
Table ????EpiVax, Inc. Profiles
Table ????EpiVax, Inc. Poxviridae Infections Drug Product Introduction
Table ????EpiVax, Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????EpiVax, Inc. SWOT Analysis
Table ????N & N Pharmaceuticals Inc. Profiles
Table ????N & N Pharmaceuticals Inc. Poxviridae Infections Drug Product Introduction
Table ????N & N Pharmaceuticals Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????N & N Pharmaceuticals Inc. SWOT Analysis
Table ????SIGA Technologies, Inc. Profiles
Table ????SIGA Technologies, Inc. Poxviridae Infections Drug Product Introduction
Table ????SIGA Technologies, Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????SIGA Technologies, Inc. SWOT Analysis
Table ????Takeda Pharmaceutical Company Limited Profiles
Table ????Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Product Introduction
Table ????Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Takeda Pharmaceutical Company Limited SWOT Analysis
Table ????Tonix Pharmaceuticals Holding Corp. Profiles
Table ????Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Product Introduction
Table ????Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Tonix Pharmaceuticals Holding Corp. SWOT Analysis
Table ????Verrica Pharmaceuticals Inc. Profiles
Table ????Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Product Introduction
Table ????Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Verrica Pharmaceuticals Inc. SWOT Analysis